Oxidative stress
The lane
- Status
- Pruned. Tested and abandoned for now.
- Verdict
- MAO-B inhibitors, urate and iron removal all failed to slow the disease.
- Family
- Housekeeping
- Landmarks
- 13 in this lane, 2 more tagged with it. Open 3 · Pending 2 · Superseded 2 · Dead end 6
The verdict and status come from the project's branches.yaml and use research wording.
Landmarks in this lane
| DATATOP: deprenyl | 1987–1993 | Trial in people | Replaced by a newer approach | – | 800 | 19 Oct 2026 | 4 |
| Iron and neuromelanin in the nigra | 1988–2019 | Discovery | Still being studied | – | – | 19 Oct 2026 | 4 |
| Glutathione loss in the nigra | 1994 | Discovery | Still being studied | – | – | 19 Oct 2026 | 2 |
| TEMPO: rasagiline delayed start | 2002–2009 | Trial in people | Replaced by a newer approach | 3 | 404 | 19 Oct 2026 | 2 |
| Urate epidemiology | 2007–2008 | Discovery | Did not hold up | – | – | 19 Oct 2026 | 2 |
| ADAGIO: rasagiline | 2009 | Trial in people | Did not work | 3 | 1,176 | 19 Oct 2026 | 5 |
| Molecular hydrogen trials | 2013–2021 | Trial in people | Did not work | 2 | 178 | 19 Oct 2026 | 3 |
| Mendelian randomisation: urate and BMI | 2014–2021 | Discovery | Did not hold up | – | – | 19 Oct 2026 | 1 |
| N-acetylcysteine (Monti) | 2014–2027 | Trial in people | Result due Jan 2027 | 2 | 50 | 22 Oct 2026 | 4 |
| Intranasal glutathione, Phase IIb | 2015–2017 | Trial in people | Mixed or early results | 2 | 45 | 19 Oct 2026 | 2 |
| SURE-PD3: inosine | 2021 | Trial in people | Did not work | 3 | 298 | 19 Oct 2026 | 2 |
| FAIRPARK-II: deferiprone | 2022 | Trial in people | Did not work | 2 | 372 | 19 Oct 2026 | 1 |
| NOSE-PD: nasal insulin plus glutathione | 2022–2027 | Trial in people | Result due Nov 2027 | 2 | 56 | 18 Oct 2026 | 3 |
Also tagged with this lane
| Ferroptosis in dopamine neurons | 2012–2016 | Discovery | Still being studied | – | – | 19 Oct 2026 | 4 |
| Dopamine oxidation damages the lysosome | 2017 | Discovery | Still being studied | – | – | 20 Oct 2026 | 3 |
Links with other lanes
Built on work from
- Foundations: 2 links
- Mitochondria & energy: 1 link
- Environment & lifestyle: 1 link
- Infrastructure & funding: 1 link
- Biomarkers: 1 link
- Trial methods & regulation: 1 link
Led to work in
- Trial methods & regulation: 4 links
- Cell survival & anti-apoptosis: 3 links
- Biomarkers: 1 link
- Mitochondria & energy: 1 link